Time course of biochemical and immunohistological alterations during experimental allergic encephalomyelitis

Neurochemistry International

Volumn 29, Issue 6, 1996, Pages 597-605

  Slavin, Daniela A ^a   Bucher, Ana E ^a   Degano, Alicia L ^a   Soria, Néstor W ^a   Roth, German A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ANTIBODY; CEREBROSIDE; CHOLESTEROL; CHOLESTEROL ESTER; IMMUNOGLOBULIN; LIPID; MYELIN; MYELIN BASIC PROTEIN; SULFATIDE; SYNAPSIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; CATTLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVITY; FEMALE; HINDLIMB; IMMUNOHISTOLOGY; INFLAMMATION; MALE; MENINX; MONONUCLEAR CELL; MOTONEURON; MYELIN SHEATH; NEUROLOGIC DISEASE; NONHUMAN; PARALYSIS; PARENCHYMA; PRIORITY JOURNAL; RAT; SENSITIZATION; SPINAL CORD; SYMPTOM; TIME;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MYELIN SHEATH; NEURONS; RATS; RATS, WISTAR; TIME FACTORS; TITRIMETRY;

ANIMALIA; BOS TAURUS; BOVINAE; RATTUS NORVEGICUS;

EID: 0030561096     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00061-7     Document Type: Article

References (47)

1. Autilio L.A., Norton W.T., Terry R.D. The preparation and some properties of purified myelin from the central nervous system. J. Neurochem. 11:1964;17-27.
2. Bieger D., White S.R. Anatomical evidence for bulbospinal monoamine axon damage in rats with experimental allergic encephalomyelitis. Circ. Res. 18:1981;118-125.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Clemons C.S., Fan K. 2′,3′-cyclic nucleotide 3′-phosphohydrolase activity in brain of acute experimental allergic encephalomyelitis. Brain Res. 169:1979;620-624.
5. De Camilli P., Cameron R., Greengard P. Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections J. Cell Biol. 96:1983;1337-1354.
6. De Santis M.L., Roth G.A., Cumar F.A. Cellular immune crossreactivity between myelin basic protein and synapsin in rats with experimental allergic encephalomyelitis. J. Neurosci. Res. 31:1992;46-51.
7. De Santis M.L., Roth G.A. Experimental allergic encephalomyelitis: characterization of T-lymphocytes that bind myelin basic protein and synapsin. J. Neurosci. Res. 43:1996;50-54.
8. Hashim G.A. Neural antigens and the development of autoimmunity. J. Immunol. 135((Suppl)):1985;838-842.
9. Juhler M., Barry D.I., Offner H., Konat G., Klinden L., Paulson O.B. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res. 302:1984;347-355.
10. Juhler M., Laursen H., Barry D.I. The distribution of immunoglobulins and albumin in the central nervous system in acute experimental encephalomyelitis. Acta Neurol. Scand. 73:1985;119-124.
11. Kato S., Nakamura H. Ultrastructural and ultracytochemical studies on the blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis. Acta Neuropath. 77:1989;455-464.
12. Kraft, G.H. and Slimp, J.C. (1984) Electrophysiological monitoring of experimental allergic neuritis and experimental allergic encephalomyelitis. In Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis, ed. Alvord, E.C., Kies, M.W. and Suckling, A.J., pp. 449-453. Alan R. Liss, Inc., New York.
13. Kristensson K., Wisniewski H.M. Chronic relapsing experimental allergic encephalomyelitis: studies in vascular permeability changes. Acta Neuropath. 39:1977;189-194.
14. Lampert P. Electron microscopic studies on ordinary and hyperacute experimental allergic encephalomyelitis. Acta Neuropathol. 9:1967;99-126.
15. Lassmann H., Kitz K., Wisniewski H.M. Structural variability of demyelinating lesions in different models of subacute and chronic experimental allergic encephalomyelitis. Acta Neuropathol. (Berl.). 51:1980;191-201.
16. Linington C., Bradl M., Lassmann H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:1988;443-454.
17. Lyman W.D., Roth G.A., Chiu F.-C., Brosnan C.F., Bornstein M.B., Raine C.S. Antigen-specific T-cells can mediate demyelination in organotypic central nervous system cultures. Cell. Immunol. 102:1986;217-226.
18. Lyman W.D., Roth G.A., Brosnan C.F., Bornstein M.B., Raine C.S. Quantitation of antigen-specific T cell-induced demyelination in vitro. J. Neuroimmunol. 17:1988;175-180.
19. Macala L.J., Yu R.K., Ando S. Analysis of brain lipids by high-performance thin-layer chromatography and densitometry. J. Lipid Res. 24:1983;1143-1150.
20. Maggio B., Cumar F.A. Experimental allergic encephalomyelitis: dissociation of neurological symptoms from lipid alterations in brain. Nature. 253:1975;364-365.
21. Maggio B., Cumar F.A., Roth G.A., Monferrán C.G., Fidelio G.D. Neurochemical and model membrane studies in demyelinating diseases. Acta Neuropathol. (Berlin). 9((Suppl)):1983;71-85.
22. Mizutamari R.K., Wiegandt H., Nores G.A. Characterization of anti-ganglioside antibodies present in normal human plasma. J. Neuroimmunol. 50:1994;215-220.
23. Norton, W.T. and Cammer, W. (1984) Isolation and characterization of myelin. In Myelin, ed. Morell, P., pp. 147-195. Plenum Press, New York.
24. Pedraza L.T., Roth G.A., Cumar F.A. Identification as synapsin of a synaptosomal protein immunoreacting with anti-myelin basic protein antiserum. J. Neurochem. 51:1988;413-420.
25. Prohaska J.R., Clark D.A., Wells W.W. Improved rapidity and precision in the determination of brain 2′,3′-cyclic nucleotide 3′-phosphohydrolase. Anal. Biochem. 56:1973;275-282.
26. Raine C.S. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 50:1984;608-635.
27. Raine C.S., Hummelgard A., Swanson E., Bornstein M.B. Multiple sclerosis: serum-induced demyelination in vitro. A light and electron microscope study. J. Neurol. Sci. 20:1973;127-148.
28. Raine C.S., Traugott U., Farooq M., Bornstein M.B., Norton W.T. Augmentation of immune-mediated demyelination by lipid haptens. Lab. Invest. 45:1981;174-182.
29. Roth G.A., Maggio B., Monferrán C.G., Cumar F.A. Experimental allergic encephalomyelitis. Identification of the myelin component responsible for the appearance of brain esterified cholesterol. FEBS Letts. 86:1978;29-32.
30. Roth G.A., Monferrá C.G., Maggio B., Cumar F.A. Central nervous system lipid alterations in rats with experimental allergic encephalomyelitis and its suppression by immunosuppressive drugs. Life Sci. 30:1982;859-866.
31. Roth G.A., Yu R.K., Bornstein M.B. Chemical analysis of organotypic cultures of mouse spinal cord in normal, demyelinative, and nondemyelinative conditions. J. Neurochem. 41:1983;1710-1717.
32. Roth G.A., Röyttä M., Yu R.K., Raine C.S., Bornstein M.B. Antisera to different glycoliipids induce myelin alterations in mouse spinal cord tissue cultures. Brain Res. 339:1985;9-18.
33. Roth G.A., Obata K. Experimental allergic encephalomyelitis: dissociation of immunochemical and clinicopathological responses in two strains of rats. Neurochem. Int. 19:1991;213-220.
34. Röyttä M., Lyman W.D., Roth G.A., Bornstein M.B., Raine C.S. Preliminary analysis of cell and serum-induced demyelination in vitro using a syngenic system. Acta Neurol. Scand. 71:1985;226-236.
35. Sadler R.H., Sommer M.A., Forno L.S., Smith M.E. Induction of anti-myelin antibodies in EAE and their possible role in demyelination. J. Neurosci. Res. 30:1991;616-624.
36. Salvati S., D'Urso D., Conti Devirgilis L., Serlupi Crescenzi G. Biochemical changes in central nervous system membranes in experimental allergic encephalomyelitis. J. Neurochem. 47:1986;239-244.
37. Schiebler W., Jahn R., Doucet J.P., Rothlein J., Greengard P. Characterization of synapsin I binding to small synaptic vesicles. J. biol. Chem. 261:1986;8383-8390.
38. Shaw, C.M. and Alvord, E.C. (1984) A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis. In Experimental allergic encephalomyelitis: A useful model for Multiple sclerosis, ed. Alvord, E.C., Kies, M.W. and Suckling, A.J., pp. 61-66. Alan R. Liss, Inc. and New York.
39. Tabira T. Autoimmune demyelination in the central nervous system. Ann. N.Y. Acad. Sci. 540:1988;187-201.
40. Traugott U., Shevach E., Chiba J., Stone S.H., Raine C.S. Acute experimental encephalomyelitis: T-and B-cell distribution within the target organ. Cell. Immunol. 70:1982;345-356.
41. Tsukada, Y. and Kurihara, T. (1992) 2′,3′-Cyclic nucleotide 3′-phosphodiesterase: molecular characterization and possible functional significance. In Myelin: Biology and Chemistry, ed. Martenson, R.F., pp. 449-480. CRC Press, Boca Raton, FL.
42. Vandenbark A.A., Burger D.R., Vetto R.M. Cell-mediated immunity in experimental allergic encephalomyelitis: crossreactivity between myelin basic protein and mycobacteria antigens. Proc. Soc. Exp. Biol. Med. 148:1975;1233-1236.
43. Wekerle H. T-cell autoimmunity in the central nervous system. Intervirology. 35:1993;95-100.
44. White S.R., Vyas D., Bieger D. Serotonin immunoreactivity in spinal cord axons and terminals of rodents with experimental allergic encephalomyelitis. Neuroscience. 16:1985;701-709.
45. White S.R., Samathanam G.K., Bowker R.M., Wessendorf M.W. Damage to bulbospinal serotonin-, tyrosine hydroxylase-, and TRH-containing axons occurs early in the development of experimental allergic encephalomyelitis in rats. J. Neurosci. Res. 27:1990;89-98.
46. Yu R.K., Ueno K., Glasser G.H., Tourtellotte W. Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis. J. Neurochem. 39:1982;464-477.
47. Zamvil S.S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:1990;579-621.